Lin, C., Woods, A., Li, Z., Leone, S., Dworkin, E., Kahla, J., … Norsworthy, K. (2025). Real-world practice patterns of IDH inhibitors and outcomes of on-label IDH inhibitor use for Acute Myeloid Leukemia in the United States. In Blood (Vol. 146, pp. 1614–1614). American Society of Hematology. https://doi.org/10.1182/blood-2025-1614

Lin, Chenyu, Ashley Woods, Zhiguo Li, Sami Leone, Emily Dworkin, Justin Kahla, Moiez Ali, et al. “Real-world practice patterns of IDH inhibitors and outcomes of on-label IDH inhibitor use for Acute Myeloid Leukemia in the United States.” In Blood, 146:1614–1614. American Society of Hematology, 2025. https://doi.org/10.1182/blood-2025-1614.

Lin C, Woods A, Li Z, Leone S, Dworkin E, Kahla J, et al. Real-world practice patterns of IDH inhibitors and outcomes of on-label IDH inhibitor use for Acute Myeloid Leukemia in the United States. In: Blood. American Society of Hematology; 2025. p. 1614–1614.

Lin, Chenyu, et al. “Real-world practice patterns of IDH inhibitors and outcomes of on-label IDH inhibitor use for Acute Myeloid Leukemia in the United States.” Blood, vol. 146, no. Supplement 1, American Society of Hematology, 2025, pp. 1614–1614. Crossref, doi:10.1182/blood-2025-1614.

Lin C, Woods A, Li Z, Leone S, Dworkin E, Kahla J, Ali M, Raptis N, Abaza Y, Lokhandwala A, Martins de Oliveira Filho C, Lee M, Taborda C, Bewersdorf JP, Ritchie J, Coltoff A, Ormond S, Burkart M, Dulak D, Im A, Kumar M, Song A, Iyer S, Guru Murthy GS, Zhou K, Scobie M, Lewis-Gonzalez J, Foucar C, Atallah E, Winer E, Erba H, LeBlanc T, Pulte ED, Wynne J, Patel A, Badar T, Norsworthy K. Real-world practice patterns of IDH inhibitors and outcomes of on-label IDH inhibitor use for Acute Myeloid Leukemia in the United States. Blood. American Society of Hematology; 2025. p. 1614–1614.